Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-04-03, Stock:LLY, The news for the past five days is as follows:
2019-03-27: NEWS1: 5 Cancer-Fighting Stocks to Boost Portfolio Gains.NEWS2: 5 Cancer-Fighting Stocks to Boost Portfolio Gains.NEWS3: 5 Cancer-Fighting Stocks to Boost Portfolio Gains.NEWS4: Lilly (LLY) Signs New Immunology Deal With Private Biotech.NEWS5: Lilly (LLY) Signs New Immunology Deal With Private Biotech.NEWS6: Lilly (LLY) Signs New Immunology Deal With Private Biotech.NEWS7: The Daily Biotech Pulse: FDA Nod For Novartis, Jazz Positive Late-Stage Data For Sleep Disorder Drug, Genfit IPO.NEWS8: Better Buy: Eli Lilly vs. GlaxoSmithKline.
2019-03-28: NEWS1: Cramer's lightning round: Don't buy this low-reward, high-risk stock.
2019-03-29: NEWS1: This Dow stock could be a way to play catch-up to the rally.NEWS2: Wall Street is buzzing about Gilead’s rheumatoid arthritis drug. Here’s why.NEWS3: Pharma Stock Roundup: AZN Inks Cancer Deal, ABBV, NVS & Others Get Drug Approvals.NEWS4: Pharma Stock Roundup: AZN Inks Cancer Deal, ABBV, NVS & Others Get Drug Approvals.NEWS5: Jim Cramer Advised His Viewers On Canopy Growth, DowDuPont And More.
2019-04-01: NEWS1: 3 Big Pharma Stocks to Add to Your Portfolio This April.NEWS2: 3 Big Pharma Stocks to Add to Your Portfolio This April.NEWS3: BMO’s Got A Point About Teva Stock, But Are Investors Willing To Listen?.NEWS4: BMO’s Got A Point About Teva Stock, But Are Investors Willing To Listen?.NEWS5: 3 Big Pharma Stocks to Add to Your Portfolio This April.NEWS6: BMO’s Got A Point About Teva Stock, But Are Investors Willing To Listen?.NEWS7: Arteaus Therapeutics Sells Emgality Royalty to Royalty Pharma for $260 Million.
2019-04-02: NEWS1: Teva's Anti-CGRP Injection Ajovy Gets Approval in Europe.NEWS2: Teva's Anti-CGRP Injection Ajovy Gets Approval in Europe.NEWS3: Merck's Keytruda Gets Nod for First-Line Lung Cancer in China.NEWS4: Merck's Keytruda Gets Nod for First-Line Lung Cancer in China.NEWS5: AVEO Reports Positive Results on Leukemia Drug, Shares Up.NEWS6: AVEO Reports Positive Results on Leukemia Drug, Shares Up.NEWS7: AVEO Reports Positive Results on Leukemia Drug, Shares Up.NEWS8: Merck's Keytruda Gets Nod for First-Line Lung Cancer in China.NEWS9: Teva's Anti-CGRP Injection Ajovy Gets Approval in Europe.

Answer: Decrease